Biocon's chairwoman, Kiran Mazumdar-Shaw, says the company's base business of manufacturing and research services have done extremely well in the first quarter but the licensing income was muted. Biocon's consolidated net profit declined 8.71 per cent to Rs 70.05 crore for the quarter ended June 30.